Report Cover

Global and Japan Cyanocobalamin Injection Market Insights, Forecast to 2026


Cyanocobalamin Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cyanocobalamin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Cyanocobalamin Injection market is segmented into
    Vitamins
    Supplements

Segment by Application, the Cyanocobalamin Injection market is segmented into
    Hospitals
    Clinics
    Others

Regional and Country-level Analysis
The Cyanocobalamin Injection market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cyanocobalamin Injection market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Cyanocobalamin Injection Market Share Analysis
Cyanocobalamin Injection market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cyanocobalamin Injection business, the date to enter into the Cyanocobalamin Injection market, Cyanocobalamin Injection product introduction, recent developments, etc.
The major vendors covered:
    Luitpold Pharmaceuticals
    Luitpold Pharmaceuticals (Daiichi Sankyo)
    Endo International
    Bristol-Myers Squibb
    Sanofi-Aventis
    Jamieson
    Teva (Actavis)
    Merck
    Mylan
    Bayer HealthCare
    Pfizer
    ANGELINI
    Biological E
    CCEPCD
    Huaxin Pharmaceutical
1 Study Coverage
    1.1 Cyanocobalamin Injection Product Introduction
    1.2 Market Segments
    1.3 Key Cyanocobalamin Injection Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Cyanocobalamin Injection Market Size Growth Rate by Type
        1.4.2 Vitamins
        1.4.3 Supplements
    1.5 Market by Application
        1.5.1 Global Cyanocobalamin Injection Market Size Growth Rate by Application
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Cyanocobalamin Injection Market Size, Estimates and Forecasts
        2.1.1 Global Cyanocobalamin Injection Revenue 2015-2026
        2.1.2 Global Cyanocobalamin Injection Sales 2015-2026
    2.2 Global Cyanocobalamin Injection, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Cyanocobalamin Injection Historical Market Size by Region (2015-2020)
        2.3.1 Global Cyanocobalamin Injection Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Cyanocobalamin Injection Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Cyanocobalamin Injection Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Cyanocobalamin Injection Sales Forecast by Region (2021-2026)
        2.4.2 Global Cyanocobalamin Injection Revenue Forecast by Region (2021-2026)

3 Global Cyanocobalamin Injection Competitor Landscape by Players
    3.1 Global Top Cyanocobalamin Injection Sales by Manufacturers
        3.1.1 Global Cyanocobalamin Injection Sales by Manufacturers (2015-2020)
        3.1.2 Global Cyanocobalamin Injection Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Cyanocobalamin Injection Manufacturers by Revenue
        3.2.1 Global Cyanocobalamin Injection Revenue by Manufacturers (2015-2020)
        3.2.2 Global Cyanocobalamin Injection Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Cyanocobalamin Injection Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Cyanocobalamin Injection Revenue in 2019
        3.2.5 Global Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Cyanocobalamin Injection Price by Manufacturers
    3.4 Global Cyanocobalamin Injection Manufacturing Base Distribution, Product Types
        3.4.1 Cyanocobalamin Injection Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Cyanocobalamin Injection Product Type
        3.4.3 Date of International Manufacturers Enter into Cyanocobalamin Injection Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Cyanocobalamin Injection Market Size by Type (2015-2020)
        4.1.1 Global Cyanocobalamin Injection Sales by Type (2015-2020)
        4.1.2 Global Cyanocobalamin Injection Revenue by Type (2015-2020)
        4.1.3 Cyanocobalamin Injection Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Cyanocobalamin Injection Market Size Forecast by Type (2021-2026)
        4.2.1 Global Cyanocobalamin Injection Sales Forecast by Type (2021-2026)
        4.2.2 Global Cyanocobalamin Injection Revenue Forecast by Type (2021-2026)
        4.2.3 Cyanocobalamin Injection Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Cyanocobalamin Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Cyanocobalamin Injection Market Size by Application (2015-2020)
        5.1.1 Global Cyanocobalamin Injection Sales by Application (2015-2020)
        5.1.2 Global Cyanocobalamin Injection Revenue by Application (2015-2020)
        5.1.3 Cyanocobalamin Injection Price by Application (2015-2020)
    5.2 Cyanocobalamin Injection Market Size Forecast by Application (2021-2026)
        5.2.1 Global Cyanocobalamin Injection Sales Forecast by Application (2021-2026)
        5.2.2 Global Cyanocobalamin Injection Revenue Forecast by Application (2021-2026)
        5.2.3 Global Cyanocobalamin Injection Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application
    6.1 Japan Cyanocobalamin Injection Market Size YoY Growth 2015-2026
        6.1.1 Japan Cyanocobalamin Injection Sales YoY Growth 2015-2026
        6.1.2 Japan Cyanocobalamin Injection Revenue YoY Growth 2015-2026
        6.1.3 Japan Cyanocobalamin Injection Market Share in Global Market 2015-2026
    6.2 Japan Cyanocobalamin Injection Market Size by Players (International and Local Players)
        6.2.1 Japan Top Cyanocobalamin Injection Players by Sales (2015-2020)
        6.2.2 Japan Top Cyanocobalamin Injection Players by Revenue (2015-2020)
    6.3 Japan Cyanocobalamin Injection Historic Market Review by Type (2015-2020)
        6.3.1 Japan Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
        6.3.2 Japan Cyanocobalamin Injection Revenue Market Share by Type (2015-2020)
        6.3.3 Japan Cyanocobalamin Injection Price by Type (2015-2020)
    6.4 Japan Cyanocobalamin Injection Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 Japan Cyanocobalamin Injection Sales Forecast by Type (2021-2026)
        6.4.2 Japan Cyanocobalamin Injection Revenue Forecast by Type (2021-2026)
        6.4.3 Japan Cyanocobalamin Injection Price Forecast by Type (2021-2026)
    6.5 Japan Cyanocobalamin Injection Historic Market Review by Application (2015-2020)
        6.5.1 Japan Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
        6.5.2 Japan Cyanocobalamin Injection Revenue Market Share by Application (2015-2020)
        6.5.3 Japan Cyanocobalamin Injection Price by Application (2015-2020)
    6.6 Japan Cyanocobalamin Injection Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 Japan Cyanocobalamin Injection Sales Forecast by Application (2021-2026)
        6.6.2 Japan Cyanocobalamin Injection Revenue Forecast by Application (2021-2026)
        6.6.3 Japan Cyanocobalamin Injection Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Cyanocobalamin Injection Market Size YoY Growth 2015-2026
    7.2 North America Cyanocobalamin Injection Market Facts & Figures by Country
        7.2.1 North America Cyanocobalamin Injection Sales by Country (2015-2020)
        7.2.2 North America Cyanocobalamin Injection Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Cyanocobalamin Injection Market Size YoY Growth 2015-2026
    8.2 Europe Cyanocobalamin Injection Market Facts & Figures by Country
        8.2.1 Europe Cyanocobalamin Injection Sales by Country
        8.2.2 Europe Cyanocobalamin Injection Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Cyanocobalamin Injection Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Country
        9.2.1 Asia Pacific Cyanocobalamin Injection Sales by Region (2015-2020)
        9.2.2 Asia Pacific Cyanocobalamin Injection Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Cyanocobalamin Injection Market Size YoY Growth 2015-2026
    10.2 Latin America Cyanocobalamin Injection Market Facts & Figures by Country
        10.2.1 Latin America Cyanocobalamin Injection Sales by Country
        10.2.2 Latin America Cyanocobalamin Injection Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Cyanocobalamin Injection Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Country
        11.2.1 Middle East and Africa Cyanocobalamin Injection Sales by Country
        11.2.2 Middle East and Africa Cyanocobalamin Injection Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Luitpold Pharmaceuticals
        12.1.1 Luitpold Pharmaceuticals Corporation Information
        12.1.2 Luitpold Pharmaceuticals Description and Business Overview
        12.1.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
        12.1.5 Luitpold Pharmaceuticals Recent Development
    12.2 Luitpold Pharmaceuticals (Daiichi Sankyo)
        12.2.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Corporation Information
        12.2.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Description and Business Overview
        12.2.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Products Offered
        12.2.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development
    12.3 Endo International
        12.3.1 Endo International Corporation Information
        12.3.2 Endo International Description and Business Overview
        12.3.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Endo International Cyanocobalamin Injection Products Offered
        12.3.5 Endo International Recent Development
    12.4 Bristol-Myers Squibb
        12.4.1 Bristol-Myers Squibb Corporation Information
        12.4.2 Bristol-Myers Squibb Description and Business Overview
        12.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Products Offered
        12.4.5 Bristol-Myers Squibb Recent Development
    12.5 Sanofi-Aventis
        12.5.1 Sanofi-Aventis Corporation Information
        12.5.2 Sanofi-Aventis Description and Business Overview
        12.5.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Sanofi-Aventis Cyanocobalamin Injection Products Offered
        12.5.5 Sanofi-Aventis Recent Development
    12.6 Jamieson
        12.6.1 Jamieson Corporation Information
        12.6.2 Jamieson Description and Business Overview
        12.6.3 Jamieson Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 Jamieson Cyanocobalamin Injection Products Offered
        12.6.5 Jamieson Recent Development
    12.7 Teva (Actavis)
        12.7.1 Teva (Actavis) Corporation Information
        12.7.2 Teva (Actavis) Description and Business Overview
        12.7.3 Teva (Actavis) Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 Teva (Actavis) Cyanocobalamin Injection Products Offered
        12.7.5 Teva (Actavis) Recent Development
    12.8 Merck
        12.8.1 Merck Corporation Information
        12.8.2 Merck Description and Business Overview
        12.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 Merck Cyanocobalamin Injection Products Offered
        12.8.5 Merck Recent Development
    12.9 Mylan
        12.9.1 Mylan Corporation Information
        12.9.2 Mylan Description and Business Overview
        12.9.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 Mylan Cyanocobalamin Injection Products Offered
        12.9.5 Mylan Recent Development
    12.10 Bayer HealthCare
        12.10.1 Bayer HealthCare Corporation Information
        12.10.2 Bayer HealthCare Description and Business Overview
        12.10.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Bayer HealthCare Cyanocobalamin Injection Products Offered
        12.10.5 Bayer HealthCare Recent Development
    12.11 Luitpold Pharmaceuticals
        12.11.1 Luitpold Pharmaceuticals Corporation Information
        12.11.2 Luitpold Pharmaceuticals Description and Business Overview
        12.11.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
        12.11.5 Luitpold Pharmaceuticals Recent Development
    12.12 ANGELINI
        12.12.1 ANGELINI Corporation Information
        12.12.2 ANGELINI Description and Business Overview
        12.12.3 ANGELINI Sales, Revenue and Gross Margin (2015-2020)
        12.12.4 ANGELINI Products Offered
        12.12.5 ANGELINI Recent Development
    12.13 Biological E
        12.13.1 Biological E Corporation Information
        12.13.2 Biological E Description and Business Overview
        12.13.3 Biological E Sales, Revenue and Gross Margin (2015-2020)
        12.13.4 Biological E Products Offered
        12.13.5 Biological E Recent Development
    12.14 CCEPCD
        12.14.1 CCEPCD Corporation Information
        12.14.2 CCEPCD Description and Business Overview
        12.14.3 CCEPCD Sales, Revenue and Gross Margin (2015-2020)
        12.14.4 CCEPCD Products Offered
        12.14.5 CCEPCD Recent Development
    12.15 Huaxin Pharmaceutical
        12.15.1 Huaxin Pharmaceutical Corporation Information
        12.15.2 Huaxin Pharmaceutical Description and Business Overview
        12.15.3 Huaxin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
        12.15.4 Huaxin Pharmaceutical Products Offered
        12.15.5 Huaxin Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Cyanocobalamin Injection Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Cyanocobalamin Injection Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Cyanocobalamin Injection Market Segments Table 2. Ranking of Global Top Cyanocobalamin Injection Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Cyanocobalamin Injection Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million) Table 4. Major Manufacturers of Vitamins Table 5. Major Manufacturers of Supplements Table 6. Global Cyanocobalamin Injection Market Size Growth Rate by Application 2020-2026 (K Doses) Table 7. Global Cyanocobalamin Injection Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026 Table 8. Global Cyanocobalamin Injection Sales by Regions 2015-2020 (K Doses) Table 9. Global Cyanocobalamin Injection Sales Market Share by Regions (2015-2020) Table 10. Global Cyanocobalamin Injection Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Cyanocobalamin Injection Sales Forecast by Region (2021-2026) (K Doses) Table 12. Global Cyanocobalamin Injection Sales by Manufacturers (2015-2020) (K Doses) Table 13. Global Cyanocobalamin Injection Sales Share by Manufacturers (2015-2020) Table 14. Global Cyanocobalamin Injection Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Cyanocobalamin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyanocobalamin Injection as of 2019) Table 16. Cyanocobalamin Injection Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Cyanocobalamin Injection Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Cyanocobalamin Injection Price (2015-2020) (USD/Dose) Table 19. Cyanocobalamin Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Cyanocobalamin Injection Product Type Table 21. Date of International Manufacturers Enter into Cyanocobalamin Injection Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Cyanocobalamin Injection Sales by Type (2015-2020) (K Doses) Table 24. Global Cyanocobalamin Injection Sales Share by Type (2015-2020) Table 25. Global Cyanocobalamin Injection Revenue by Type (2015-2020) (US$ Million) Table 26. Global Cyanocobalamin Injection Revenue Share by Type (2015-2020) Table 27. Cyanocobalamin Injection Average Selling Price (ASP) by Type 2015-2020 (USD/Dose) Table 28. Global Cyanocobalamin Injection Sales Share by Type (2021-2026) Table 29. Global Cyanocobalamin Injection Sales by Application (2015-2020) (K Doses) Table 30. Global Cyanocobalamin Injection Sales Share by Application (2015-2020) Table 31. Global Cyanocobalamin Injection Sales Share by Application (2021-2026) Table 32. Global Cyanocobalamin Injection Sales Market Share Forecast by Application (2021-2026) Table 33. Global Cyanocobalamin Injection Revenue by Application (2015-2020) (US$ Million) Table 34. Global Cyanocobalamin Injection Revenue Market Share Forecast by Application (2021-2026) Table 35. Japan Cyanocobalamin Injection Sales (K Doses) of Key Companies (2015-2020) Table 36. Japan Cyanocobalamin Injection Sales Share by Company (2015-2020) Table 37. Japan Cyanocobalamin Injection Revenue (US$ Million) by Company (2015-2020) Table 38. Japan Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020) Table 39. Japan Cyanocobalamin Injection Sales Share by Type (2015-2020) Table 40. Japan Cyanocobalamin Injection Revenue (US$ Million) Market Share by Type (2015-2020) Table 41. Japan Cyanocobalamin Injection Price (K Doses) by Type (2015-2020) Table 42. Japan Cyanocobalamin Injection Sales (K Doses) by Type (2021-2026) Table 43. Japan Cyanocobalamin Injection Sales Share by Type (2021-2026) Table 44. Japan Cyanocobalamin Injection Revenue (US$ Million) Market Share by Type (2021-2026) Table 45. Japan Cyanocobalamin Injection Revenue Share by Type (2021-2026) Table 46. Japan Cyanocobalamin Injection Price (K Doses) by Type (2021-2026) Table 47. Japan Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020) Table 48. Japan Cyanocobalamin Injection Sales Share by Application (2015-2020) Table 49. Japan Cyanocobalamin Injection Revenue (US$ Million) Market Share by Application (2015-2020) Table 50. Japan Cyanocobalamin Injection Sales (K Doses) by Application (2021-2026) Table 51. Japan Cyanocobalamin Injection Sales Share by Application (2021-2026) Table 52. Japan Cyanocobalamin Injection Revenue (US$ Million) Market Share by Application (2021-2026) Table 53. Japan Cyanocobalamin Injection Revenue Share by Application (2021-2026) Table 54. North America Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses) Table 55. North America Cyanocobalamin Injection Sales Market Share by Country (2015-2020) Table 56. North America Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million) Table 57. North America Cyanocobalamin Injection Revenue Market Share by Country (2015-2020) Table 58. Europe Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses) Table 59. Europe Cyanocobalamin Injection Sales Market Share by Country (2015-2020) Table 60. Europe Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million) Table 61. Europe Cyanocobalamin Injection Revenue Market Share by Country (2015-2020) Table 62. Asia Pacific Cyanocobalamin Injection Sales by Region (2015-2020) (K Doses) Table 63. Asia Pacific Cyanocobalamin Injection Sales Market Share by Region (2015-2020) Table 64. Asia Pacific Cyanocobalamin Injection Revenue by Region (2015-2020) (US$ Million) Table 65. Asia Pacific Cyanocobalamin Injection Revenue Market Share by Region (2015-2020) Table 66. Latin America Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses) Table 67. Latin America Cyanocobalamin Injection Sales Market Share by Country (2015-2020) Table 68. Latin Americaa Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million) Table 69. Latin America Cyanocobalamin Injection Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Cyanocobalamin Injection Sales by Country (2015-2020) (K Doses) Table 71. Middle East and Africa Cyanocobalamin Injection Sales Market Share by Country (2015-2020) Table 72. Middle East and Africa Cyanocobalamin Injection Revenue by Country (2015-2020) (US$ Million) Table 73. Middle East and Africa Cyanocobalamin Injection Revenue Market Share by Country (2015-2020) Table 74. Luitpold Pharmaceuticals Corporation Information Table 75. Luitpold Pharmaceuticals Description and Business Overview Table 76. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 77. Luitpold Pharmaceuticals Cyanocobalamin Injection Product Table 78. Luitpold Pharmaceuticals Recent Development Table 79. Luitpold Pharmaceuticals (Daiichi Sankyo) Corporation Information Table 80. Luitpold Pharmaceuticals (Daiichi Sankyo) Description and Business Overview Table 81. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 82. Luitpold Pharmaceuticals (Daiichi Sankyo) Product Table 83. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development Table 84. Endo International Corporation Information Table 85. Endo International Description and Business Overview Table 86. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 87. Endo International Product Table 88. Endo International Recent Development Table 89. Bristol-Myers Squibb Corporation Information Table 90. Bristol-Myers Squibb Description and Business Overview Table 91. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 92. Bristol-Myers Squibb Product Table 93. Bristol-Myers Squibb Recent Development Table 94. Sanofi-Aventis Corporation Information Table 95. Sanofi-Aventis Description and Business Overview Table 96. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 97. Sanofi-Aventis Product Table 98. Sanofi-Aventis Recent Development Table 99. Jamieson Corporation Information Table 100. Jamieson Description and Business Overview Table 101. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 102. Jamieson Product Table 103. Jamieson Recent Development Table 104. Teva (Actavis) Corporation Information Table 105. Teva (Actavis) Description and Business Overview Table 106. Teva (Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 107. Teva (Actavis) Product Table 108. Teva (Actavis) Recent Development Table 109. Merck Corporation Information Table 110. Merck Description and Business Overview Table 111. Merck Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 112. Merck Product Table 113. Merck Recent Development Table 114. Mylan Corporation Information Table 115. Mylan Description and Business Overview Table 116. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 117. Mylan Product Table 118. Mylan Recent Development Table 119. Bayer HealthCare Corporation Information Table 120. Bayer HealthCare Description and Business Overview Table 121. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 122. Bayer HealthCare Product Table 123. Bayer HealthCare Recent Development Table 124. Pfizer Corporation Information Table 125. Pfizer Description and Business Overview Table 126. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 127. Pfizer Product Table 128. Pfizer Recent Development Table 129. ANGELINI Corporation Information Table 130. ANGELINI Description and Business Overview Table 131. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 132. ANGELINI Product Table 133. ANGELINI Recent Development Table 134. Biological E Corporation Information Table 135. Biological E Description and Business Overview Table 136. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 137. Biological E Product Table 138. Biological E Recent Development Table 139. CCEPCD Corporation Information Table 140. CCEPCD Description and Business Overview Table 141. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 142. CCEPCD Product Table 143. CCEPCD Recent Development Table 144. Huaxin Pharmaceutical Corporation Information Table 145. Huaxin Pharmaceutical Description and Business Overview Table 146. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 147. Huaxin Pharmaceutical Product Table 148. Huaxin Pharmaceutical Recent Development Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 150. Key Challenges Table 151. Market Risks Table 152. Main Points Interviewed from Key Cyanocobalamin Injection Players Table 153. Cyanocobalamin Injection Customers List Table 154. Cyanocobalamin Injection Distributors List Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Cyanocobalamin Injection Product Picture Figure 2. Global Cyanocobalamin Injection Sales Market Share by Type in 2020 & 2026 Figure 3. Vitamins Product Picture Figure 4. Supplements Product Picture Figure 5. Global Cyanocobalamin Injection Sales Market Share by Application in 2020 & 2026 Figure 6. Hospitals Figure 7. Clinics Figure 8. Others Figure 9. Cyanocobalamin Injection Report Years Considered Figure 10. Global Cyanocobalamin Injection Market Size 2015-2026 (US$ Million) Figure 11. Global Cyanocobalamin Injection Sales 2015-2026 (K Doses) Figure 12. Global Cyanocobalamin Injection Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Cyanocobalamin Injection Sales Market Share by Region (2015-2020) Figure 14. Global Cyanocobalamin Injection Sales Market Share by Region in 2019 Figure 15. Global Cyanocobalamin Injection Revenue Market Share by Region (2015-2020) Figure 16. Global Cyanocobalamin Injection Revenue Market Share by Region in 2019 Figure 17. Global Cyanocobalamin Injection Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Cyanocobalamin Injection Revenue in 2019 Figure 19. Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Cyanocobalamin Injection Sales Market Share by Type (2015-2020) Figure 21. Global Cyanocobalamin Injection Sales Market Share by Type in 2019 Figure 22. Global Cyanocobalamin Injection Revenue Market Share by Type (2015-2020) Figure 23. Global Cyanocobalamin Injection Revenue Market Share by Type in 2019 Figure 24. Global Cyanocobalamin Injection Market Share by Price Range (2015-2020) Figure 25. Global Cyanocobalamin Injection Sales Market Share by Application (2015-2020) Figure 26. Global Cyanocobalamin Injection Sales Market Share by Application in 2019 Figure 27. Global Cyanocobalamin Injection Revenue Market Share by Application (2015-2020) Figure 28. Global Cyanocobalamin Injection Revenue Market Share by Application in 2019 Figure 29. Japan Cyanocobalamin Injection Sales Growth Rate 2015-2026 (K Doses) Figure 30. Japan Cyanocobalamin Injection Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. Japan Cyanocobalamin Injection Market Share in Global Market 2015-2026 Figure 32. Japan 5 and 10 Largest Cyanocobalamin Injection Players Market Share by Revenue in Cyanocobalamin Injection in 2019 Figure 33. Japan Cyanocobalamin Injection Revenue Share by Type (2015-2020) Figure 34. Japan Cyanocobalamin Injection Revenue Growth Rate by Type in 2015 & 2019 Figure 35. Japan Cyanocobalamin Injection Revenue Share by Application (2015-2020) Figure 36. Japan Cyanocobalamin Injection Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses) Figure 38. North America Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America Cyanocobalamin Injection Sales Market Share by Country in 2019 Figure 40. North America Cyanocobalamin Injection Revenue Market Share by Country in 2019 Figure 41. U.S. Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 42. U.S. Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 44. Canada Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses) Figure 46. Europe Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Cyanocobalamin Injection Sales Market Share by Country in 2019 Figure 48. Europe Cyanocobalamin Injection Revenue Market Share by Country in 2019 Figure 49. Germany Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 50. Germany Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 52. France Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 54. U.K. Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 56. Italy Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 58. Russia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses) Figure 60. Asia Pacific Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Cyanocobalamin Injection Sales Market Share by Region in 2019 Figure 62. Asia Pacific Cyanocobalamin Injection Revenue Market Share by Region in 2019 Figure 63. China Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 64. China Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 66. Japan Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 68. South Korea Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 70. India Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 72. Australia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 74. Taiwan Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 76. Indonesia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 78. Thailand Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 80. Malaysia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 82. Philippines Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 84. Vietnam Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses) Figure 86. Latin America Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Cyanocobalamin Injection Sales Market Share by Country in 2019 Figure 88. Latin America Cyanocobalamin Injection Revenue Market Share by Country in 2019 Figure 89. Mexico Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 90. Mexico Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 92. Brazil Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 94. Argentina Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa Cyanocobalamin Injection Sales Growth Rate 2015-2020 (K Doses) Figure 96. Middle East and Africa Cyanocobalamin Injection Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Cyanocobalamin Injection Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Cyanocobalamin Injection Revenue Market Share by Country in 2019 Figure 99. Turkey Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 100. Turkey Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 102. Saudi Arabia Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Cyanocobalamin Injection Sales Growth Rate (2015-2020) (K Doses) Figure 104. U.A.E Cyanocobalamin Injection Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. Cyanocobalamin Injection Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global and Japan cPDM in Fabrication and Assembly Market Size, Status and Forecast 2020-2026

Global cPDM in Fabrication and Assembly Scope and Market Size cPDM in Fabrication and Assembly market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global cPDM in Fabrication and Assembly market will ...

Global and China cPDM in Electrical and Electronics Market Size, Status and Forecast 2020-2026

Global cPDM in Electrical and Electronics Scope and Market Size cPDM in Electrical and Electronics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global cPDM in Electrical and Electronics market...

Global and United States cPDM in Automotive Market Size, Status and Forecast 2020-2026

Global cPDM in Automotive Scope and Market Size cPDM in Automotive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global cPDM in Automotive market will be able to gain the upper hand as they use...

Global and China cPDM in AeroSpace and Defence Market Size, Status and Forecast 2020-2026

Global cPDM in AeroSpace and Defence Scope and Market Size cPDM in AeroSpace and Defence market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global cPDM in AeroSpace and Defence market will be able t...

Global and United States Collaborative Product Definition Management (cPDM) Market Size, Status and Forecast 2020-2026

Global Collaborative Product Definition Management (cPDM) Scope and Market Size Collaborative Product Definition Management (cPDM) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Collabora...

Publisher: QY Research
Chat with us